New WHO Guideline Redefines Infertility as a Universal Health Priority

What if infertility was no longer a private struggle, but a public health priority and basic human right? The new World Health Organization (WHO) guideline for infertility prevention, diagnosis, and treatment signals a dramatic shift: infertility is now recognized as a medical condition requiring systematic, equitable, and evidence-based care.

The WHO Guideline: A Global Action Plan

The new guideline, published in Int J Gynecol Obstet, offers 40 recommendations and six good practice statements. It reframes infertility as a critical health and social issue—affecting one in six people worldwide—and calls for its integration into national health strategies.

Key pillars include:

Pragmatic, history-driven diagnosis: Targeted testing based on clinical findings (e.g., mid-luteal progesterone for ovulation, tubal assessment, structured semen analysis), avoiding unnecessary upfront tests.

Prevention and education: Routine fertility education, lifestyle counseling, smoking cessation, and early management of sexually transmitted infections.

Shared decision-making: Emphasis on psychosocial support and respect for patient values, not just technology-driven interventions.

Equitable access: Fertility care should be provided regardless of marital status, gender, sexual orientation, or socioeconomic background.

Practical Guidance for All Health Systems

Unlike regional guidelines (ASRM, ESHRE, ASPIRE) that assume broad access to advanced technology, the WHO guideline is adaptable for diverse economic settings. Cost-effective first-line treatments (like letrozole for ovulatory disorders) and stepwise management for unexplained infertility are recommended before advanced procedures like IVF.

FIGO’s position is closely aligned: fertility care should be context-specific, non-discriminatory, and incorporated into public health systems, not just private clinics.

Addressing Stigma, Gaps, and Systemic Barriers

The guideline recognizes the stigma and discrimination surrounding infertility—especially for women, who may face blame or intimate partner violence. It also acknowledges key gaps:

Fertility preservation and third-party reproduction (e.g., surrogacy, gamete donation) require future guideline updates.

Male-factor infertility and modern lifestyle risks need more attention.

Endometriosis diagnosis is moving towards non-surgical imaging, reducing “unexplained” infertility rates.

Why This Matters for Clinicians

The new WHO guideline is more than a clinical checklist—it’s a call for policy, awareness, and health system transformation. By reframing infertility as part of universal health coverage, it aims to reduce global disparities, financial hardship, and social isolation. Clinicians are encouraged to advocate for resource-sensitive, patient-centered care and to help reduce stigma and barriers wherever they practice.

Key points

WHO’s new guideline defines infertility as a universal health right and a public health priority.

Recommendations focus on cost-effective, pragmatic diagnosis and prevention—adaptable to all resource levels.

Equity is central: fertility care should not be limited by marital status, gender, or socioeconomic status.

Stigma reduction and policy integration are as important as technical guidance.

Future updates are expected on fertility preservation, third-party reproduction, male-factor infertility, and endometriosis.

Citation:

Hull ML, Barnhart KT, Purandare NC, Sridhar A, Topçu EG, Nelson SM. The new WHO infertility guideline: A universal right to equitable, evidence-based fertility care. Int J Gynecol Obstet. 2026;00:1-4. doi:10.1002/ijgo.71380